The Los Angeles Chargers today announced the addition of Adam Fuller as safeties coach to Head Coach Jim Harbaugh’s coaching ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

Retired New York Giants quarterback Eli Manning is a finalist for this year’s class for induction into the Pro Football Hall of Fame. His presence is ubiquitous due to his massive endorsements ...

TUPELO – Aubrey Patterson, who helped grow the former Bank of Mississippi, now Cadence Bank, into a $13 billion financial institution, has died. He was 82. Born in Grenada in 1942, Patterson ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December scripts boost. The stock is attractively valued at current levels. Eli ...

The FDA ap­proved Eli Lil­ly’s Omvoh in Crohn’s dis­ease, the com­pa­ny an­nounced Wednes­day, hand­ing the drug its sec­ond in­di­ca­tion af­ter giv­ing it a green light … ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...

What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...

Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall ...

Ryan Patterson was one of five Tigers to place over the weekend, competing in the Hastings Open. In the 197 pound weight class, Patterson finished second, winning by major decision, decision 5-4 ...

Eli Lilly (NYSE:LLY) shares sold off on Tuesday after the Indiana-based pharma giant's Q4 and 2024 preliminary sales results for its obesity therapy tirzepatide fell short of Street forecasts ...

Global pharmaceutical company Eli Lilly's (LLY) preliminary 2024 revenue missed expectations on lower-than-expected sales of its weight loss and diabetes shots. According to the company ...